期刊文献+

高血压病患者高密度脂蛋白抗低密度脂蛋白氧化能力降低 被引量:2

Impaired Antioxidant Activity of High Density Lipoprotein in Patients with Essential Hypertension
下载PDF
导出
摘要 目的观察高血压病患者高密度脂蛋白抗氧化活性有无变化及可能的影响因素。方法纳入33名高血压病患者及32名健康对照者,采用一次性密度梯度超速离心法分离高密度脂蛋白及低密度脂蛋白,体外Cu2+诱导法作脂蛋白氧化,用分光光度法、硫代巴比妥酸法测定高密度脂蛋白抗氧化能力、氧化延迟时间和体外过氧化程度,分光光度仪连续监测法测定血清对氧磷酶1活性。结果高血压病患者与正常对照组比较,高密度脂蛋白抗氧化活性及对氧磷酶1活性下降(P均<0.05),高密度脂蛋白氧化延迟时间、体外过氧化程度差异没有统计学意义;高密度脂蛋白抗氧化活性与对氧磷酶1活性呈正相关,与收缩压、舒张压和总胆固醇浓度呈负相关(r分别为0.317、-0.387、-0.42和-0.259,P均<0.05)。结论高血压病患者高密度脂蛋白抗氧化活性降低可能是易患动脉粥样硬化的重要因素。血压、对氧磷酶1活性等影响高密度脂蛋白抗氧化活性。 Aim To compare the differences of high density lipoprotein(HDL) antioxidant activity between normal people and the essential hypertension patients,and to explore the factors that may affect the antioxidant capacity of HDL. Methods Thirty-three patients with essential hypertension and 32 normal people were included.HDL and low density lipoprotein(LDL) were isolated by one-step density grandient ultracentrifugation,and induced oxidation with external Cu 2+.Antioxidant activity of HDL,lag time,lipid peroxidation degree were determined by spectrophotometric and thiobarbituric acid reactive substances methods.Paraoxonase 1(PON1) activity was measured with continuous monitoring using phenylacetate as substrate.Results In essential hypertension patients,the inhibitory effect of HDL on LDL oxidation and the activity of PON1 were reduced(P〈 0.05),the lag time of oxidation and the lipid peroxidation degree did not show statistically significant difference.HDL antioxidant capacity was positively correlated with PON1 activity and negatively correlated with systolic pressure,diastolic pressure,and total cholesterol level(with r= 0.317,-0.387,-0.42,-0.259 respectively,P〈 0.05).Conclusions HDL antioxidant activity may be one of the most important determinants for the development of atherosclerosis in patients with essential hypertension.The impaired HDL antioxidant activity is affected by high levels of blood pressure,and low activity of PON1.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第12期909-912,共4页 Chinese Journal of Arteriosclerosis
基金 四川省科技攻关项目资助课题(07KJT-05)
关键词 内科学 高血压病 高密度脂蛋白 低密度脂蛋白 脂质氧化 抗氧化 动脉粥样硬化 Essential Hypertension High Density Lipoproteins Low Density Lipoprotein Lipid Peroxidation Antioxidant Atherosclerosis
  • 相关文献

参考文献3

二级参考文献73

共引文献42

同被引文献30

  • 1王瑜敏,黄海霞,袁谦.肺癌患者放疗过程中血脂的动态变化及意义[J].江西医学检验,2005,23(2):129-130. 被引量:9
  • 2Lloyd-Jones DM, Evans JC, Larson MG, et al. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study[J]. Arch Intern Med, 1999, 159(18): 2206-2212.
  • 3Gordon D J, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies[J]. Circulation, 1989, 79(1): 8-15.
  • 4Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment[J]. Circulation, 1992, 85(1): 37-45.
  • 5Ansell B J, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment[J].Circulation, 2003, 108(22): 2751-2756.
  • 6Gerstein HC, Mann JF, Pogue J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators[J]. Diabetes Care, 2000, 23(Suppl 2): B35-B39.
  • 7Wachtell K, Ibsen H, Olsen MH, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the life study[J]. Ann Intern Med, 2003,t(11): 901-906.
  • 8Ravera M, Ratto E, Vettoretti S, et al. Microalbumiia indicates subclinical cerebrovascular damage in patients with essential hypertension[J]. J Nephrol, 2002, 15(5): 519-524.
  • 9Chobanian AV, Bakris GL, Black HR. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report[J]. Hypertension, 2003, 12 (4): 31-32.
  • 10Rodbard HW, Blonde L, Braithwaite SS, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus[J]. Endocr Pract, 2007, 13(Suppl 1): 1-68.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部